| 000 | 02814nam a22004695i 4500 | ||
|---|---|---|---|
| 001 | 978-3-642-30726-3 | ||
| 003 | DE-He213 | ||
| 005 | 20140220083319.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 121009s2012 gw | s |||| 0|eng d | ||
| 020 |
_a9783642307263 _9978-3-642-30726-3 |
||
| 024 | 7 |
_a10.1007/978-3-642-30726-3 _2doi |
|
| 050 | 4 | _aRM1-950 | |
| 072 | 7 |
_aMMG _2bicssc |
|
| 072 | 7 |
_aMED071000 _2bisacsh |
|
| 082 | 0 | 4 |
_a615 _223 |
| 100 | 1 |
_aRegitz-Zagrosek, Vera. _eeditor. |
|
| 245 | 1 | 0 |
_aSex and Gender Differences in Pharmacology _h[electronic resource] / _cedited by Vera Regitz-Zagrosek. |
| 264 | 1 |
_aBerlin, Heidelberg : _bSpringer Berlin Heidelberg : _bImprint: Springer, _c2012. |
|
| 300 |
_aIX, 600 p. 37 illus., 22 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 1 |
_aHandbook of Experimental Pharmacology, _x0171-2004 ; _v214 |
|
| 505 | 0 | _aFrom the contents -- Preface -- Part 1: Sex differences in mechanisms of disease -- Part 2: Sex differences in pharmacokinetics, in drug development and use -- Part 3: Sex differences in different therapeutic areas. | |
| 520 | _aThis is the very first book to deal with sex and gender differences in drug therapy - an increasingly recognized medical need. It starts with an overview on S/G in clinical syndromes and a documentation of the medical and socioeconomic damage caused by gender specific adverse drug effects. Part I covers S/G differences in pharmacokinetics. Researchers will be satisfied by the detailed discussion of the mechanisms of S/G differences in drug effects that represents cutting edge science and includes interaction of drugs with sex hormones, genomic and epigenetic mechanisms. It also covers S/G in drug development, in animal models and clinical development and S/G in drug prescriptions. Part II targets S/G differences in drug effects in cardiovascular, pulmonary, CNS, neuromuscular, neuropsychiatric and metabolic diseases, in cancer, inflammation, and rheumatic diseases, in bacterial and retroviral infections, thrombosis, embolism. New drugs will be discussed. | ||
| 650 | 0 | _aMedicine. | |
| 650 | 0 | _aToxicology. | |
| 650 | 0 | _aPharmaceutical technology. | |
| 650 | 1 | 4 | _aBiomedicine. |
| 650 | 2 | 4 | _aPharmacology/Toxicology. |
| 650 | 2 | 4 | _aMolecular Medicine. |
| 650 | 2 | 4 | _aPharmaceutical Sciences/Technology. |
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9783642307256 |
| 830 | 0 |
_aHandbook of Experimental Pharmacology, _x0171-2004 ; _v214 |
|
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-3-642-30726-3 |
| 912 | _aZDB-2-SBL | ||
| 999 |
_c103233 _d103233 |
||